Kevin Conroy

Type: Person
Name: Kevin Conroy
First reported Apr 08 2014 - Updated Apr 09 2014 - 2 reports

Exact Sciences raises nearly $120M, focused on a hoped-for 2014 launch of its colon cancer Dx

Exact Sciences ($EXAS) President and CEO Kevin Conroy previously promised that 2014 will be all about getting the company's Cologuard colon cancer test to market. Now, the company will be armed with close to $120 million to get the job done.The Wisconsin ... [Published Fierce BioMarkers - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Student’s Grade 9 choice of applied math led to Grade 12 shock

Angela Frias had to make a choice in Grade 9. It turned out to be a fateful one.She’d been struggling in academic math, and she wasn’t sure whether to stay the course or switch to applied math, a curriculum based more on hands-on learning.In the end, ... [Published Toronto Observer - Apr 08 2014]
First reported Mar 28 2014 - Updated Mar 29 2014 - 1 reports

FDA Gives At-Home Colon Cancer Test With 93.3% Sensitivity Unanimous Support

A panel of advisers from the Food and Drug Administration announced on Thursday their unanimous support for Cologuard, an at-home test for colon cancer that boasts 92.3 percent sensitivity at detecting tumors and precancerous lesions.Colorectal cancer ... [Published Medical Daily - Mar 28 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 2 reports

Exact Sciences wins unanimous FDA committee approval for its colon cancer Dx

Exact Sciences CEO Kevin ConroyExact Sciences ($EXAS) won unanimous FDA committee approval for its stool-based cancer diagnostic, moving the company one step closer to receiving full regulatory clearance for the test.The Molecular and Clinical Genetics ... [Published FierceMedicalDevices - Mar 28 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

FDA Panel Gives Exacts Colon Cancer Test Ringing Endorsement

It was all smiles and congratulatory handshakes for Exact Sciences president and CEO Kevin Conroy this afternoon after a panel of physicians and medical experts unanimously endorsed the Madison, WI-based company’s colon cancer screening test for FD.. ... [Published BioPortfolio - Mar 27 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

FDA to discuss Exact Sciences' test results

Officials at Exact Sciences Corp. are preparing to answer tough questions this week from the FDA, which meets to discuss the results of the Madison company’s stool-based test for colon cancer. Thus far, the company’s test has been shown in clinical trials ... [Published IB Madison - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

The Dreaded Turning-50 Test

One of the joys of turning 50 is that your doctor will start recommending a colonoscopy . Many people dread the test, which involves having a tube inserted into the rectum to look for cancers and precancers.Even so, acceptance has grown tremendously. ... [Published Gnom.es - Mar 24 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

Exact Sciences chairman resigns; stock takes a hit

said Friday its chairman has resigned and chief executive officer Kevin Conroy has been appointed chairman of the board.James Connelly submitted his resignation on Monday, the Madison company said, citing personal reasons.In a document filed with federal ... [Published Capital Times - Mar 21 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 3 reports

Exact Sciences Corp announces appointment of Kevin Conroy as Chairman

Exact Sciences Corp:Appoints Kevin T. Conroy, the company's president and chief executive, as chairman of board. ... [Published Reuters - Mar 21 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 2 reports

Exact Sciences’ Colon Cancer Test Clears Key Hurdle, FDA Next

Wall Street was pleased today with the newly published results of a pivotal study of Exact Sciences’ non-invasive screening test for colorectal cancer. Next step for the Madison, WI, company: FDA approval.Exact (NASDAQ: EXAS) announced top-line data of ... [Published Xconomy - Mar 19 2014]
First reported Mar 13 2014 - Updated Mar 14 2014 - 2 reports

Sotheby’s Rejects Third Point Board Nominees, Proposals For Change

Sotheby’s has dismissed the three director candidates proffered by Third Point and offered a pair of independent candidates of its own.The auction house said it had reviewed Third Point’s nominees, which include Third Point founder and frequent Sotheby’s ... [Published FINalternatives - Mar 14 2014]
First reported Mar 05 2014 - Updated Mar 05 2014 - 1 reports

​Batman: Arkham Knight Won't Have Multiplayer, Will Have Kevin Conroy

Sounds like the newest Batman game, Arkham Knight, won't just ship without a last-gen version ; it also won't include multiplayer. However, it will feature longtime Batman voice actor Kevin Conroy, reprising his role as Batman. Read more... ... [Published Kotaku - Mar 05 2014]

Quotes

...and updates like they never have before,' said Kevin Conroy , president, Digital and Enterprise Development, Univision Communications Inc. "fans will be able to customize their viewing experience with a broad array of personalization alerts and favorites as well as sharing across their favorite social networks."
"during 2013 we … focused on commercial readiness and operational excellence, and are well prepared for cologuard's launch, pending fda approval" Conroy said in a statement issued in February...
"you can grow up in dublin and still not know much about it" said Kevin Conroy, 69, a retired Dublin businessman and a published poet who wished the tour had provided more history of some of the places, like the...
"We are pleased the Committee strongly supported Cologuard's approval," Exact Chairman and CEO Kevin Conroy said in a statement. "we look forward to continuing our work with the fda to complete its review of cologuard and remain committed to addressing the growing unmet needs in colorectal cancer screening."

More Content

All (46) | News (42) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
WisBusiness: The Show - Idle Free Systems CEO R... [Published Wis Business.com - Apr 18 2014]
Permit granted for 31-unit development on Liber... [Published Record-Journal.com - Apr 16 2014]
NEULION : New univision deportes app delivers l... [Published 4 Traders - Apr 14 2014]
Marion area students participate in YMCA Youth ... [Published Marion Star - Apr 12 2014]
Student’s Grade 9 choice of applied math led to... [Published Toronto Observer - Apr 08 2014]
Exact Sciences raises nearly $120M, focused on ... [Published Fierce BioMarkers - Apr 08 2014]
Licensed video games that are fun and cost effi... [Published U-Wire.com - Apr 08 2014]
Dublin's gritty Northside feted in tour of poet... [Published TrustMedia - Apr 08 2014]
In wake of panel approval, Exact Sciences’ Colo... [Published IB Madison - Apr 08 2014]
TOP 8 LICENSED VIDEO GAMES [Published 411mania.com - Apr 08 2014]
Obama for America's Digital Director Teddy Goff... [Published I Stock Analyst - Apr 03 2014]
Exact Sciences' and Epigenomics' colon cancer t... [Published Fierce BioMarkers - Apr 01 2014]
My Little Pony Fans Stampede into Lewisville, P... [Published Dallas Observer - Mar 31 2014]
FDA Gives At-Home Colon Cancer Test With 93.3% ... [Published Medical Daily - Mar 28 2014]
Exact Sciences wins unanimous FDA committee app... [Published FierceMedicalDevices - Mar 28 2014]
MADISON - Exact Sciences' Cologuard gets FDA co... [Published BizTimes Milwaukee - Mar 28 2014]
Exact Sciences' Cologuard gets FDA committee no... [Published BusinessWeek - Mar 28 2014]
FDA Panel Gives Exact’s Colon Cancer Test Ringi... [Published Xconomy - Mar 27 2014]
FDA Panel Gives Exacts Colon Cancer Test Ringin... [Published BioPortfolio - Mar 27 2014]
WisBusiness: The Show - John Biondi, director o... [Published Wis Business.com - Mar 27 2014]
FDA to discuss Exact Sciences' test results [Published IB Madison - Mar 25 2014]
The Dreaded Turning-50 Test [Published Gnom.es - Mar 24 2014]
Exact Sciences chairman resigns; stock takes a hit [Published Capital Times - Mar 21 2014]
Exact Sciences Corp announces appointment of Ke... [Published Reuters - Mar 21 2014]
Exact Sciences Announces Appointment of Kevin C... [Published CNBC - Mar 21 2014]
Exact Sciences Announces Appointment of Kevin C... [Published Business Wire Health News - Mar 21 2014]
Many Paths: One Result [Published NonProfit Times - Mar 20 2014]
‘Kano assembly passed 50 bills in 3 years’ [Published Daily Trust - Mar 20 2014]
Exact Sciences’ Colon Cancer Test Clears Key Hu... [Published Xconomy - Mar 19 2014]
NEJM publishes results from Exact's pivotal col... [Published FierceMedicalDevices - Mar 19 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Exact Sciences Announces Appointment of Kevin C... [Published Business Wire Health News - Mar 21 2014]
MADISON, Wis.--(BUSINESS WIRE)--Kevin Conroy has been appointed Exact's chairman of the board. David Thompson will serve as lead independent director. James Connelly has resigned as chairman of the board. ...
Arkham Knight Has No Multiplayer, Kevin Conroy ... [Published IGN Entertainment - YouTube - Mar 05 2014]
<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=rHPlauZCDwE&feature=youtube_gdata"&gt;Arkham Knight Has No Multiplayer, Kevin Conroy Returns as Batman Batman: Arkham Knight will not have multiplayer, ...
​Batman: Arkham Knight Won&#39;t Have Multiplay... [Published Kotaku - Mar 05 2014]
Sounds like the newest Batman game, Arkham Knight, won't just ship without a last-gen version ; it also won't include multiplayer. However, it will feature longtime Batman voice actor Kevin Conroy, reprising his role as Batman. Read more... ...
Enterprise Software Company Blue Rooster Raises... [Published TechCrunch - Oct 22 2013]
Enterprise software company Blue Rooster announced today that it has raised $3 million from PFU Limited , a wholly owned subsidiary of Fujitsu. Seattle-based Blue Rooster said the funding is the first installment in a multi-stage investment that ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.